Huntington National Bank’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-46
| Closed | -$333 | – | 4191 |
|
|
2025
Q3 | $333 | Hold |
46
| – | – | ﹤0.01% | 2463 |
|
|
2025
Q2 | $244 | Buy |
46
+18
| +64% | +$106 | ﹤0.01% | 2563 |
|
|
2025
Q1 | $248 | Buy |
+28
| New | +$336 | ﹤0.01% | 2597 |
|
|
2024
Q4 | – | Sell |
-17
| Closed | -$466 | – | 4207 |
|
|
2024
Q3 | $466 | Hold |
17
| – | – | ﹤0.01% | 2495 |
|
|
2024
Q2 | $416 | Buy |
+17
| New | +$373 | ﹤0.01% | 2447 |
|
|
2023
Q4 | – | Sell |
-199
| Closed | -$3.19K | – | 3919 |
|
|
2023
Q3 | $3.19K | Sell |
199
-60
| -23% | -$1.14K | ﹤0.01% | 1954 |
|
|
2023
Q2 | $6K | Buy |
259
+83
| +47% | +$1.81K | ﹤0.01% | 1740 |
|
|
2023
Q1 | $4.09K | Hold |
176
| – | – | ﹤0.01% | 1788 |
|
|
2022
Q4 | $2.55K | Hold |
176
| – | – | ﹤0.01% | 1727 |
|
|
2022
Q3 | $3K | Hold |
176
| – | – | ﹤0.01% | 1796 |
|
|
2022
Q2 | $3K | Hold |
176
| – | – | ﹤0.01% | 1842 |
|
|
2022
Q1 | $4K | Hold |
176
| – | – | ﹤0.01% | 1800 |
|
|
2021
Q4 | $5K | Hold |
176
| – | – | ﹤0.01% | 1731 |
|
|
2021
Q3 | $6K | Sell |
176
-222
| -56% | -$7.37K | ﹤0.01% | 1555 |
|
|
2021
Q2 | $12K | Hold |
398
| – | – | ﹤0.01% | 1411 |
|
|
2021
Q1 | $12K | Hold |
398
| – | – | ﹤0.01% | 1292 |
|
|
2020
Q4 | $8K | Buy |
398
+222
| +126% | +$3.58K | ﹤0.01% | 1337 |
|
|
2020
Q3 | $2K | Hold |
176
| – | – | ﹤0.01% | 1436 |
|
|
2020
Q2 | $2K | Sell |
176
-22
| -11% | -$312 | ﹤0.01% | 1424 |
|
|
2020
Q1 | $3K | Hold |
198
| – | – | ﹤0.01% | 1406 |
|
|
2019
Q4 | $5K | Hold |
198
| – | – | ﹤0.01% | 1500 |
|
|
2019
Q3 | $6K | Hold |
198
| – | – | ﹤0.01% | 1347 |
|
|
2019
Q2 | $6K | Hold |
198
| – | – | ﹤0.01% | 1382 |
|
|
2019
Q1 | $7K | Hold |
198
| – | – | ﹤0.01% | 1338 |
|
|
2018
Q4 | $6K | Hold |
198
| – | – | ﹤0.01% | 1396 |
|
|
2018
Q3 | $9K | Hold |
198
| – | – | ﹤0.01% | 1404 |
|
|
2018
Q2 | $7K | Hold |
198
| – | – | ﹤0.01% | 1391 |
|
|
2018
Q1 | $6K | Hold |
198
| – | – | ﹤0.01% | 1406 |
|
|
2017
Q4 | $7K | Sell |
198
-23
| -10% | -$776 | ﹤0.01% | 1411 |
|
|
2017
Q3 | $8K | Buy |
221
+70
| +46% | +$2K | ﹤0.01% | 1390 |
|
|
2017
Q2 | $4K | Buy |
+151
| New | +$3.21K | ﹤0.01% | 1410 |
|
|
2015
Q3 | – | Sell |
-3,707
| Closed | -$126K | – | 1767 |
|
|
2015
Q2 | $126K | Buy |
+3,707
| New | +$126K | ﹤0.01% | 847 |
|
|
2014
Q4 | – | Sell |
-220,000
| Closed | -$8.48M | – | 1750 |
|
|
2014
Q3 | $8.48M | Buy |
220,000
+28,140
| +15% | +$1.05M | 0.17% | 142 |
|
|
2014
Q2 | $7.47M | Buy |
191,860
+10,422
| +6% | +$388K | 0.15% | 164 |
|
|
2014
Q1 | $6.2M | Buy |
181,438
+176,385
| +3,491% | +$5.46M | 0.12% | 210 |
|
|
2013
Q4 | $106K | Sell |
5,053
-18
| -0.4% | -$455 | ﹤0.01% | 892 |
|
|
2013
Q3 | $119K | Buy |
5,071
+639
| +14% | +$18.2K | ﹤0.01% | 817 |
|
|
2013
Q2 | $119K | Buy |
+4,432
| New | +$128K | ﹤0.01% | 793 |
|
Other funds holding MYGN
GCM
Huntington National Bank's MYGN Position: Q4 2025 in Review
Huntington National Bank sold out of Myriad Genetics (MYGN) in Q4 2025, closing a stake of 46 shares — an estimated $333 sold.
Huntington National Bank first reported a position in MYGN in Q2 2013 and held it in 38 quarters. The position peaked at $8.48M in Q3 2014. 221 funds tracked by Wall St. Rank hold MYGN as of Q4 2025.
- Huntington National Bank reported no remaining Myriad Genetics position as of Q4 2025 after selling out during the quarter.
- Huntington National Bank sold 46 Myriad Genetics shares in Q4 2025, an estimated $333.
- Huntington National Bank first reported a position in Myriad Genetics in Q2 2013 and held it in 38 quarters.
- Huntington National Bank's Myriad Genetics position peaked at $8.48M in Q3 2014.
- 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2025.
Based on Huntington National Bank's 13F filing for Q4 2025, filed 9 Feb 2026.